CDKN2A and lung adenocarcinoma: In the GSE10072 array, expression levels of CDKN2A, PHLDA2, and SFN are significantly upregulated in lung adenocarcinoma compared to normal lung tissue in several datasets (Figure 5A–5C), and NDRG4 is downregulated (Figure 5D).